Join us in online on 21 March, 2023 for this exclusive webinar on Going to Europe: A new strategy for Chinese Life Sciences with Prof. Eric Bouteiller, Jing Wang and Olivier Daubry

About this webinar

China is open again and we hope that Covid 19 is behind us. This means more Chinese healthcare companies are looking at investment opportunities. To “go overseas” (出海) is a hot topic on many boards.

But where to go? What kind of product range and commercial strategy is the right one? How can companies adapt to local realities? How can geopolitical situations be navigated? What kind of support, partners, and services is Europe looking for? There are many things to consider.

Join us for this insightful webinar where we will dive into these key questions and more, with our guests who have decades of first-hand experience in the Lifesciences industry in China.

Our speakers

Jing Wang, Chief Commercial Officer & Executive Director, CanSino Biologics Inc

Global EMBA, CEIBS

Ms. Wang holds a bachelor degree in Economics, a master degree in engineering from Peking University and a Global EMBA from CEIBS. She joined CanSino in 2012. Ms. Wang has led the establishment of the financing, financial operations, human resource and administration systems as well as completing the pre-IPO fundraising, the IPO on Main Board of Hong Kong Stock Exchange in 2019 and on the Sci-tech Innovation Board of the Shanghai Stock Exchange in 2020.

Olivier Daubry, CEO & Founder, AsiaBioNext Pte Ltd

Olivier has more than 35 years of leadership and business transformation experience in the biopharmaceutical sector. He holds a successful track-record in executive roles at corporate, regional and affiliate level in Europe, the United States and Asia-Pacific such as with Sanofi (5 years), GSK (15 years) and Celgene (11 years). Since 2018, Olivier is CEO and Founder of AsiaBioNext, a strategic consulting and BD firm based in Singapore and operating globally. AsiaBioNext supports R&D based US and EU Biopharma companies to expand to Asia, and Asian Biopharmas to expand globally, either directly or through cross-border strategic partnership.

Prof. Eric Bouteiller, Adjunct Professor of Management at CEIBS
Professor Bouteiller holds a PhD in Organisational Sociology, he began his career with HEC Eurasia Institute. He joined Ipsen Pharma in 2001 as China GM, becoming SVP Asia from 2012-2017. During his career he has held senior roles in several industry organizations, including RDPAC for which he was Vice-Chairman and Chairman. In 2013, he founded the French Healthcare Alliance in China and in 2018 he co-founded JUMO Partners.

.

Organiser

CEIBS Zurich Campus

Event details

Date & Time: Tuesday March 21, 2023 @ 13:00- 14:00 CET

Venue: Online

Language: English

Registration: Please register via Zoom: https://ceibs.zoom.us/webinar/register/WN_UVYQyOVoT12DX_DfHfp0hg